Axonics

Axonics Current Ratio

Current Ratio of Axonics (AXNX) as of Nov 19, 2026.

Current Ratio

-

Last updated:

Current Ratio of Axonics is 2026 - . Current Ratio of Axonics was 2025 - . It decreases by % lower compared to the previous year.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Axonics Stock analysis

What does Axonics do? Axonics Modulation Technologies Inc. is a medical device company that was founded in 2013 and is headquartered in Irvine, California. The company specializes in the development and marketing of innovative therapy devices for the treatment of bladder dysfunction and bowel diseases. Axonics is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Axonics stock

On Eulerpool you can find the complete historical development of Current Ratio Axonics since 2006 – with annual values, charts, and detailed analysis.

The Current Ratio measures a company's ability to pay short-term obligations. A ratio above 1 indicates that current assets exceed current liabilities.

Current Ratio = Current Assets / Current Liabilities

A 'good' varies by industry and company stage. On Eulerpool, you can compare Current Ratio's Axonics with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Axonics

All Key Metrics — Axonics